Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NICHOLS et al v. COCRYSTAL PHARMA, INC. et al
Case Number:
2:19-cv-16751
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
-
September 04, 2020
Cocrystal Pharma's Reforms To End $27M Stock Plot Suits
Cocrystal Pharma Inc. will implement a series of corporate reforms to settle three derivative suits brought by shareholders over an alleged $27 million pump-and-dump scheme that drove down the value of the company's stock, according to a motion Friday in New Jersey federal court seeking preliminary approval of the deal.
-
June 08, 2020
Talks Underway To End Cocrystal Pharma Stock-Drop Suit
Settlement talks are underway in a derivative suit brought by Cocrystal Pharma Inc. shareholders over a $27 million pump-and-dump scheme that purportedly drove down the value of the company's stock, according to a New Jersey federal court filing Monday.
-
August 16, 2019
Biotech Investors Allege $27M Pump-And-Dump Scheme
Shareholders of BioZone Pharmaceuticals Inc.'s successor slammed its former executives and high-profile investors with a lawsuit Thursday alleging they ensnared the company in a $27 million pump-and-dump scheme that drove down the value of its stock.